The Effects of Combined Treatment with an HMG-CoA Reductase Inhibitor and PPARγ Agonist on the Activation of Rat Pancreatic Stellate Cells.

Gut and Liver
Beom Jae LeeHo Sang Ryu

Abstract

Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) and peroxisome proliferator-activated receptor gamma (PPARγ) ligands can modulate cellular differentiation, proliferation, and apoptosis through various pathways. It has been shown that HMG-CoA reductase inhibitors and PPARγ agonists separately inhibit pancreatic stellate cell (PaSC) activation. We studied the effects of a combination of both types of drugs on activated PaSCs via platelet-derived growth factor (PDGF), which has not previously been reported. The present study was performed to elucidate the underlying mechanisms of these effects by focusing on the impact of the signaling associated with cell-cycle progression. Primary cultures of rat PaSCs were exposed to simvastatin and troglitazone. Proliferation was quantified using the BrdU method, and cell-cycle analysis was performed using a fluorescent activated cell sorter. The protein expression levels of smooth muscle actin (SMA), extracellular signal-regulated kinase (ERK), and a cell cycle machinery protein (p27Kip1) were investigated using Western blot analysis. Simvastatin reversed the effects of PDGF on cell proliferation in a dose-dependent manner. The combination of a low concentration o...Continue Reading

References

Oct 9, 1999·The American Journal of Pathology·P S HaberJ S Wilson
Sep 2, 2000·The Journal of Biological Chemistry·T MiyaharaH Tsukamoto
Feb 17, 2001·Gastroenterology·B Etemad, D C Whitcomb
Mar 10, 2001·Nature·L Chang, M Karin
Oct 19, 2001·The Journal of Biological Chemistry·Atsushi MasamuneTooru Shimosegawa
Apr 3, 2002·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·O GripS Lindgren
Jan 7, 2004·Nature Reviews. Cancer·Liliane MichalikWalter Wahli
Feb 24, 2004·American Journal of Physiology. Gastrointestinal and Liver Physiology·Gisela SparmannJörg Emmrich
Mar 16, 2004·American Journal of Physiology. Gastrointestinal and Liver Physiology·Yoshikuni NagashioMakoto Otsuki
Aug 25, 2004·Cancer Treatment Reviews·Stamos TheocharisGregory Kouraklis
Sep 16, 2004·The Journal of Pharmacology and Experimental Therapeutics·Atsushi MasamuneTooru Shimosegawa
Aug 12, 2005·International Journal of Cancer. Journal International Du Cancer·Chih-Jung YaoShuang-En Chuang
Dec 29, 2005·Biochemical and Biophysical Research Communications·Kouji HamaKentaro Sugano
Mar 22, 2006·The Oncologist·Katja HindlerCharles D Collard
Jan 4, 2007·The Journal of Clinical Investigation·M Bishr OmaryStephen J Pandol
Apr 28, 2007·American Journal of Physiology. Gastrointestinal and Liver Physiology·C Y IvashchenkoR M Mortensen
Jun 21, 2007·Molecular Cancer Research : MCR·Fu-Sheng ChouJoseph J Pinzone
Oct 27, 2007·American Journal of Physiology. Gastrointestinal and Liver Physiology·Atsushi MasamuneTooru Shimosegawa
Mar 15, 2008·Liver International : Official Journal of the International Association for the Study of the Liver·Isabella ApriglianoBernhard Saile
Apr 3, 2008·Current Opinion in Urology·Robert J Hamilton, Stephen J Freedland
Dec 5, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Atsushi MasamuneTooru Shimosegawa
Jul 28, 2010·Gut·Marc BardouMyriam Martel

❮ Previous
Next ❯

Citations

Feb 18, 2017·World Journal of Gastroenterology : WJG·Ratnakar R BynigeriRupjyoti Talukdar
Aug 6, 2019·The Tohoku Journal of Experimental Medicine·Tooru Shimosegawa

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
scraping
FACS

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis